Trials / Completed
CompletedNCT01326598
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 270 (actual)
- Sponsor
- Valeritas, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the present study is to observe glycemic control, dose requirements, hypoglycemia risk, other possible adverse effects and weight changes, as well as to compare these parameters to prior treatment when patients with type 2 diabetes are initiated and treated using V-Go during circumstances as close to normal clinical practice as possible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | V-Go™ | Use of Insulin Delivery Device, V-Go, and the effect on A1C for T2DM patients in five categories of baseline oral antidiabetes drug (OAD) use with or without insulin. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-03-01
- Completion
- 2014-05-01
- First posted
- 2011-03-31
- Last updated
- 2015-06-02
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01326598. Inclusion in this directory is not an endorsement.